SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

UPLOAD Filing

IM Cannabis Corp.
Date: Aug. 20, 2025 · CIK: 0001792030 · Accession: 0000000000-25-008862

Regulatory Compliance Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-289571

Date
August 20, 2025
Author
Division of
Form
UPLOAD
Company
IM Cannabis Corp.

Letter

Re: IM Cannabis Corp. Registration Statement on Form F-3 Filed August 13, 2025 File No. 333-289571 Dear Oren Shuster:

August 20, 2025

Oren Shuster Chief Executive Officer IM Cannabis Corp. 3606-833 Seymour Street Vancouver, BC, V6B 0G4, Canada

This is to advise you that we have not reviewed and will not review your registration statement.

Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Doris Stacey Gama at 202-551-3188 with any questions.

Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Oded Har-Even, Esq.

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 August 20, 2025

Oren Shuster
Chief Executive Officer
IM Cannabis Corp.
3606-833 Seymour Street
Vancouver, BC, V6B 0G4, Canada

 Re: IM Cannabis Corp.
 Registration Statement on Form F-3
 Filed August 13, 2025
 File No. 333-289571
Dear Oren Shuster:

 This is to advise you that we have not reviewed and will not review your
registration
statement.

 Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

 Please contact Doris Stacey Gama at 202-551-3188 with any questions.

 Sincerely,

 Division of
Corporation Finance
 Office of Life
Sciences
cc: Oded Har-Even, Esq.
</TEXT>
</DOCUMENT>